Saudi Arabia’s health care sector is currently undergoing major restructuring in response to rising demand and costs, driven by population growth and an increased incidence of non-communicable diseases (NCDs). At the same time, like the rest of the world, the Saudi health sector has had to contend with the threat posed by Covid-19 in the first half of 2020, with the authorities taking steps to limit both the health and economic impact of the virus. Guided by Vision 2030 – the Kingdom’s…
Health & Life Sciences
From The Report: Saudi Arabia 2020
View in Online Reader
The outlook for the health care sector remains positive despite Saudi Arabia facing a number of challenges in terms of increasing capacity to meet rising demand and a higher incidence of non-communicable diseases, as well as the more recent threat of Covid-19. The government’s efforts to restructure the public sector through decentralisation and digitalisation initiatives are increasing efficiency and reducing costs. Meanwhile, ongoing privatisation and efforts to create a more competitive health care environment are improving care and attracting significant investment. The shift towards public-private partnerships and build-operate-transfer contracts is expected to support private sector activity in the decade to come, while the burgeoning health start-up ecosystem is set to contribute to a greater level of digitalisation. This chapter contains an interview with Hisham bin Saad Aljadhey, CEO, Saudi Food and Drug Authority.